Welcome to our web-presentation of
K-BIO Institute for Cellbiotechnology and Immunology GmbH
AUTOLOGOUS CANCER VACCINE AHICE, for Cancer After-Care, against Auto-Immune Diseases, and for prevention.
Autologous cancer vaccine AHICE is advantageous because of the absence of allergic reactions and carry no risks of viral infection, like Hepatitis B or C or HIV (AIDS), etc..
On the other hand, clinical studies have shown that the autologous cancer vaccine AHICE can successfully fight human pathogenic viruses - for example, successful elimination of HPV cervical infections, which otherwise lead to cervical cancer - testify to the extraordinary effectiveness of the autologous vaccine AHICE.
Autologous cancer vaccine AHICE, is distinguished by its unique target cell specificity and selectivity against cancer- and metastatic-cells.
Normally, the recognition of cancer cells in vivo by autologous immune system is not possible, because of “escape mechanisms intelligence” of cancer cell DNA (⇒ "masking" or disguise of cell shape to escape any attack from outside, e.g. autologous immune system).
AHICE´s KEY POINT
It is therefore absolutely necessary that the "masking" of cancer cell´s surface is previously being removed / cleaved, to make them"recognisable" by autologous immune system.
Only after this AHICE pre-treatment of isolated cancer cells, body´s own immune system became able to recognise these cancer cells as differentiated pathologically.
This means, that patient’s own immune system will get specific informations of the altered shape(⇒ called morphology ⇒ Greek) of cancer cells through AHICE´s special processing(patent).
Studies have shown that this specific “antigen information” is stored in the CD45RO+ lymphocytes.
However, this antigen information is deleted / disappears due to the immunosuppressive effects of analgesics, anti-inflammatory drugs, corticoids, cytostatics and cell destruction by the action of high-energy rays!
After autologous cancer vaccine AHICE´s application, body´s immune system starts to kill the so identified cancer cells via antigen specific activation of natural killer cells(NKC´s) and very complex mechanism of programmed cell death, called “apoptosis”, as the unique intelligent, physiological “antigen-searching and selectively eliminating pharmacon (⇒ medicine)”.
This is a brief explanation of the indescribably complex immune response, which is unique intelligent directed, autonomous and auto-regulating itself (dependent on kind and amount of identified antigen), highly specific immunological / biochemical mechanism.
Autologous Cancer Vaccine, Immunotreatment AHICE. Benefits
♦ Highly target cell specificity, provided via the unique “selectivity, detection and apoptotic elimination ability against the recognised antigens of cancer cells, reached by complete “antigen specific” immune-stimulation and attack of patient’s own immune-system.
♦ There are none side effects recorded, because of the autologous production of AHICE.
♦ The in vivo Effectiveness is proved in multicentric clinical trials until now at several carcinomata.
♦ Autologous cancer immunotherapy, autologous cancer vaccine AHICE is applicable on various carcinoma-kinds and -stages (exceptions: leukaemiae / lymphomas).
♦ Autologous cancer immunotherapy AHICE can applied also in combination with the conservative tumourtherapy (e.g. radiation- and/or chemotherapy) theoretically, but, it must be emphasised, that the therapeutic effect occurred, may depend upon the high level of suppression of immune system, derived on duration and strength of applied chemotherapy or/and radiation, as this negative effect is very well known. This combination of treatments is therefore contraindicated and not recommended.
♦ Special preparations of immunological blood treatment AHICE against auto-immune diseases have recorded remarkable results therapeutically also at:
rheumatoid-arthritis, Hashimoto Thyreoiditis, auto-thrombocytopenie, Morbus Waldenström, MS, Morbus Crohn, Colitis Ulcerosa and other auto-immune-diseases (clinical trials by named oncological departments of universities).
K-BIO Institute is searching in Immunology/Biochemistry/Cell-Biology/Radio-Biology and is willing to co-operate scientifically with appropriate medicinal institutions, for broader statistical verification of the remarkable clinical AHICE treatment results.
Furthermore Informations → contact
next → Investors
next → CEO Researcher
next → medularythyroidcancer
next → AutoImmuneDiseases
next → MorbusWaldenstroem
next → peritoneal cancer
next → prostate cancer
next → morbus crohn
back → Home, Language